Dr. Ian Winchester Flinn M.D.
Hematologist-Oncologist | Hematology & Oncology
250 25th Ave N Suite 412 Nashville TN, 37203About
Dr. Ian Flinn is a hematologist oncologist practicing in Nashville, TN. Dr. Flinn specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Johns Hopkins University School of Medicine 1990
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens.
- Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.
- A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL.
- New approaches to treating malignances with stem cell transplantation.
- Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
- Monoclonal antibodies and autologous stem cell transplantation for lymphoma.
- Gemcitabine demonstrates in vitro activity against human B-cell chronic
- New approaches to blood and marrow transplantation for patients with low-grade lymphomas.
- Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma.
- The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction.
- Monoclonal antibody therapy with autologous peripheral blood stem cell
- Lymphoma therapy: the challenges ahead.
- Chronic lymphocytic leukemia: advances in biology and therapeutics.
- Incorporating monoclonal antibodies in blood and marrow transplantation.
- MALT Lymphomas.
Clinical Trials
- Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
- A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
- A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
- Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- A Study Evaluating the Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Treatments
- Anemia
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Multiple Myeloma
- Leukemia
- Dermal Aesthetics
- Oral Surgery Procedures
- Extra Corporeal Shockwave Therapy
Dr. Ian Winchester Flinn M.D.'s Practice location
Dr. Ian Winchester Flinn M.D.'s reviews
Write ReviewPatient Experience with Dr. Flinn
Recommended Articles
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial
When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
Nearby Providers
- Wendy K. Rathmell2220 Pierce Ave Nashville Tennessee 37232
- Dr. Denise A Yardley M.D.250 25th Ave N Nashville TN 37203
- Dr. Michael B Hemphill MD5653 Frist Blvd Hermitage TN 37076
- Dr. Jesus G Berdeja M.D.250 25th Ave N Nashville TN 37203
- Dr. Edward Kirk Barnes M.D.3443 Dickerson Pike Nashville TN 37207
- Dr. Igor Puzanov MD3601 The Vanderbilt Clinic Nashville TN 37232